Search

Research

Research in hematology has dramatically improved our understanding of hematologic diseases and resulted in many innovative, groundbreaking discoveries.

SPC Advisory Board, EHA Congress 2024

Current committee members
Valentine Brousse, France
Veronika Buxhofer-Ausch, Austria
Ana Cvejic, Denmark
Mattia D'Agostino, Italy
Thierry Facon, France
Krystof Giannopoulos, Poland
Julia Hauer, Germany
Dan Hodson, United Kingdom
Sören Lehmann, Sweden
Georg Lenz, Germany
Sirpa Leppä, Finland
Karina Meijer, The Netherlands
Emma Morris, United Kingdom
Cristina Papayannidis, Italy
France Pirenne, France
Delphine Rea, France
Sonata Šaulytė Trakymienė, Lithuania
Barbara…

Patient Advocacy Committee

Current committee members
Derek Elston, United Kingdom (Chair)
Androulla Eleftheriou, Cyprus (Vice-chair)
Samantha Nier (Switzerland) (Vice-chair)
Members representing a Patient Advocacy Organization

Organization
Member

Acute Leukaemia Advocates Network (ALAN)

Samantha Nier

CLL Advocates Network (CLLAN)

Pierre Aumont

CML Advocates Network

Jan Geissler

European Federation of Associations of Patients with Haemochromatosis (EFAPH)

Dag Erling Stavik

European…

Partnerships

EHA's approach to policy and regulatory affairs involves collaboration across medical professions and disciplines.

Scientific Program Committee, EHA Congress 2024

Current committee members
Brian Huntly, United Kingdom (Chair)
Martin Dreyling, Germany (Chair elect)
Konstanze Döhner, Germany (Past Chair)
Marta Morado, Spain (Local representative)
Gabriela Baerlocher, Switzerland
Tom Cupedo, The Netherlands
Florence Cymbalista, France
Mariane De Montalembert, France
Jordi Esteve, Spain
Thoas Fioretos, Sweden
Sara Ghorashian, United Kingdom
Domenico Girelli, Italy
Mats Jerkeman, Sweden
Ulrich…

EHA-NSHBT Sickle Cell Disease Webinar

EHA and the Topics-in-Focus Taskforce on Hemoglobinopathies are working with the Nigerian Society of Haematology and Blood Transfusion (NSHBT) to organize a webinar on Sickle Cell Disease (SCD).

A Special Coach for the Cantera 2024

A unique tutorial for young hematologists, co-sponsored by the EHA Lymphoma Group and the Fondazione Italiana Linfomi. DatesMay 14 to May 17, 2024. LocationLecce, Italy. TopicHow the utilization of cellular therapy strategies looks for lymphomas in 2024.

EHA-ECL led statement calls for protection of the Hospital Exemption

Feb 19 2024 Posted in Advocacy news

The hospital exemption (HE) is a vital provision within the EU's pharmaceutical legislation, currently subject to a revision.

Splenic marginal zone lymphoma study

An SWG Grant-supported project initiated by the EHA Lymphona Group.